The Value of Patient Perspectives in Answering Key Business Questions
Published March 1st, 2024 | 3 Minute Read
Patient input is vital from a commercial, research, and clinical perspective. They alone are the experts in their experience with a given condition. Enhanced understanding of the patient experience can help ensure that communications are clear and relevant to the target audience to help identify and drive patient-centered solutions and care strategies.
For over a decade, Health Union has regularly fielded condition-specific surveys within its growing portfolio of online health communities to bring the voice of the patient to the forefront. These surveys have collected thousands of responses from patients and caregivers living with a range of chronic and complex conditions. They have become deeply valuable sources – to both Health Union and industry partners – of timely, relevant, patient-reported data that offer genuine insight into the patient experience.
In recent years, Health Union’s syndicated offerings have expanded to better meet client needs, ranging from high-level reports for clients seeking condition overviews or specific data points to comprehensive reports that take an in-depth look at the patient experience. Core components of Health Union’s syndicated program include:
In America, an annual IRB-approved survey that collects condition-specific feedback from over 30,000 respondents, across 50 conditions. This streamlined survey provides high-level insights into condition impact as well as treatment awareness, use, and satisfaction and offers an opportunity to examine similarities and differences across conditions.
Patient Experience, a condition-specific, in-depth, IRB-approved research program, that focuses on quality of life, unmet needs, HCP dynamics and relationship, disease burden, treatment awareness, and treatment experiences — with quota-sampling to better represent important subgroups.
These core components mean that Health Union can now better help clients:
- Understand condition-specific patient journeys
- Validate target patient profiles (in terms of demographics, disease burden, treatment experiences, and information-seeking)
- Construct brand user profiles and how they compare to others using a competing product
- Explore varied condition experiences and the changes that occur according to line of therapy or disease stage
- Augment situation analyses and/or RWE or HEOR-related analyses
Health Union’s syndicated research harnesses patient driven insights to help brands develop foundational knowledge from the patient perspective.
Want to know if Health Union offers syndicated reports in a specific condition? The full range of available and upcoming research reports can be found here.
Interested in learning more? We invite you to fill out the form below.
Related Articles
Invisible Symptoms Impact Rheumatoid Arthritis Patients’ Lives, Hinder Diagnosis
Rheumatoid Arthritis In America 2016, a national survey by Health Union of more than 3,100 individuals who identified as having rheumatoid arthritis (RA), reveals that initial symptoms are often invisible to others, with respondents experiencing more than six on average. A summary infographic is also available. Among people with RA who took the survey, receiving a diagnosis often proved difficult with the average time between initial symptoms and diagnosis spanning four years.
Psoriatic Arthritis Patients Find Condition Difficult to Diagnose and Often Misunderstood
Psoriatic Arthritis In America 2016, is a new national survey by Health Union of over 500 individuals suffering from psoriatic arthritis (PsA). The results reveal that the diagnosis process is often frustrating and lengthy, and that most patients experience multiple symptoms before leading to a diagnosis. In addition, respondents reported difficulty explaining often invisible symptoms that progress and become more debilitating over time.
Impact of employment status on health-related quality of life for people living with autoimmune conditions
This abstract was published in 2016 showcasing data from Health Union’s PsA, RA, IBD, Plaque Psoriasis & MS In America 2016 surveys.
Related Articles
Differences in DMT treatment experiences among people with MS: Here’s what patients say
For many people living with multiple sclerosis (MS), treatment decisions can often be nuanced and complicated. In April of 2018, the American Academy of Neurology (AAN) released new guidelines about when to begin, change, and end disease-modifying therapies (DMTs) for MS patients. MS In America 2018 results may help the healthcare industry gain a broader understanding of people’s experiences, or lack thereof, with DMTs and other MS treatment options.
Survey Finds ‘Scanxiety’ Is Common Challenge for Lung Cancer Patients
Living with lung cancer is accompanied by a considerable level of anxiety, with 86 percent of respondents reporting at least a little bit of anxiety on any given day. However, what is often referred to as “scanxiety” – the anxiety, fear and worry associated with scans, specifically before the results are revealed – can exacerbate those feelings. Of those who experience scanxiety, three-quarters reported either “more” or “a lot more” anxiety around the time of scans than at other times.
Patient Centricity Starts With Patients: Closing the Trial Recruitment Gap
There is a lot of talk in the industry about patient centricity, but is it the reality? We talk about putting the needs of patients first and keeping them central in the business decisions we make across the healthcare industry. However, as we discussed on a panel at this year’s DIA 2018 Global Annual Meeting, somehow in the effort to amplify patient centricity, a critical voice is often underrepresented—the voice of the patient.






